Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10014, pp. 127 - 135
Summary Background Two large trials have reported contradictory results at 1 year after thrombus aspiration in ST elevation myocardial infarction (STEMI). In a...
Internal Medicine | MANUAL THROMBECTOMY | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | INITIAL THROMBOSUCTION | ROUTINE THROMBECTOMY | REPERFUSION | CARDIAC DEATH | PRIMARY PCI | PRIMARY ANGIOPLASTY | DISTAL EMBOLIZATION | Prospective Studies | Follow-Up Studies | Humans | Shock - epidemiology | Male | Combined Modality Therapy | Coronary Thrombosis - therapy | Myocardial Infarction - therapy | Thrombectomy | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aged | Heart Failure - epidemiology | Percutaneous Coronary Intervention | Canada | United Kingdom | Hospitals | Thrombosis | Heart attack | Blood clot | Heart failure | Medical research | Heart attacks | Mortality | Cardiology | Catheters | Clinical outcomes | Blood clots
Internal Medicine | MANUAL THROMBECTOMY | MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | IMPACT | INITIAL THROMBOSUCTION | ROUTINE THROMBECTOMY | REPERFUSION | CARDIAC DEATH | PRIMARY PCI | PRIMARY ANGIOPLASTY | DISTAL EMBOLIZATION | Prospective Studies | Follow-Up Studies | Humans | Shock - epidemiology | Male | Combined Modality Therapy | Coronary Thrombosis - therapy | Myocardial Infarction - therapy | Thrombectomy | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aged | Heart Failure - epidemiology | Percutaneous Coronary Intervention | Canada | United Kingdom | Hospitals | Thrombosis | Heart attack | Blood clot | Heart failure | Medical research | Heart attacks | Mortality | Cardiology | Catheters | Clinical outcomes | Blood clots
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 2017, Volume 33, Issue 9, pp. 1197 - 1200
Abstract Cardiovascular disease encompasses coronary artery disease and valvular heart disease, and the prevalence of both increases with age. Over the past...
Cardiovascular | STATEMENT | CARDIAC & CARDIOVASCULAR SYSTEMS | Prevalence | Canada - epidemiology | Cross-Sectional Studies | Heart Valve Diseases - epidemiology | Humans | Blood Vessel Prosthesis Implantation - methods | Cardiac Catheterization - methods | Blood Vessel Prosthesis Implantation - statistics & numerical data | Cardiac Catheterization - statistics & numerical data | Surveys and Questionnaires | Heart Valve Diseases - surgery | Retrospective Studies
Cardiovascular | STATEMENT | CARDIAC & CARDIOVASCULAR SYSTEMS | Prevalence | Canada - epidemiology | Cross-Sectional Studies | Heart Valve Diseases - epidemiology | Humans | Blood Vessel Prosthesis Implantation - methods | Cardiac Catheterization - methods | Blood Vessel Prosthesis Implantation - statistics & numerical data | Cardiac Catheterization - statistics & numerical data | Surveys and Questionnaires | Heart Valve Diseases - surgery | Retrospective Studies
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 2015, Volume 31, Issue 10, pp. 1225 - 1231
Abstract Background Because of limitations on hospital resources, patients with ST-elevation myocardial infarction (STEMI) who undergo successful primary...
Cardiovascular | DISCONTINUITY | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | THERAPY | MORBIDITY | GUIDELINES | THROMBOLYSIS | REPERFUSION | PRIMARY ANGIOPLASTY | CARE | Patient Transfer - methods | Myocardial Infarction - mortality | Outcome Assessment (Health Care) | Risk Assessment | Humans | Middle Aged | Risk Factors | Male | Myocardial Infarction - therapy | Propensity Score | Cardiology Service, Hospital - statistics & numerical data | Canada - epidemiology | Time Factors | Percutaneous Coronary Intervention - methods | Survival Analysis | Female | Patient Transfer - statistics & numerical data | Patient Readmission - statistics & numerical data | Percutaneous Coronary Intervention - adverse effects
Cardiovascular | DISCONTINUITY | PERCUTANEOUS CORONARY INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | THERAPY | MORBIDITY | GUIDELINES | THROMBOLYSIS | REPERFUSION | PRIMARY ANGIOPLASTY | CARE | Patient Transfer - methods | Myocardial Infarction - mortality | Outcome Assessment (Health Care) | Risk Assessment | Humans | Middle Aged | Risk Factors | Male | Myocardial Infarction - therapy | Propensity Score | Cardiology Service, Hospital - statistics & numerical data | Canada - epidemiology | Time Factors | Percutaneous Coronary Intervention - methods | Survival Analysis | Female | Patient Transfer - statistics & numerical data | Patient Readmission - statistics & numerical data | Percutaneous Coronary Intervention - adverse effects
Journal Article
1980, ISBN 0879333596, Volume 23., xiii, 347
Book
Canadian Journal of Cardiology, ISSN 0828-282X, 2006, Volume 22, Issue 13, pp. 1121 - 1126
Most hospitals in Canada do not have percutaneous coronary intervention (PCI) facilities and use thrombolysis as reperfusion therapy for ST-elevation...
Myocardial infarction, Thrombolysis | Clinical trials | Angioplasty | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | myocardial infarction | GUIDELINES | thrombolysis | clinical trials | PRIMARY ANGIOPLASTY | SOCIETY | angioplasty | Postoperative Complications - etiology | Follow-Up Studies | Humans | Middle Aged | Heparin - therapeutic use | Male | Myocardial Infarction - diagnostic imaging | Tissue Plasminogen Activator - therapeutic use | Enoxaparin - therapeutic use | Hospitals, Community | Angioplasty, Balloon, Coronary | Feasibility Studies | Myocardial Infarction - therapy | Time Factors | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy - methods | Adult | Female | Myocardial Infarction - physiopathology | Tenecteplase | Myocardial Infarction - etiology | Stents | Coronary Stenosis - diagnostic imaging | Length of Stay | Coronary Stenosis - complications | Coronary Stenosis - therapy | Treatment Outcome | Coronary Angiography | Pilot Projects | Heart Conduction System - physiopathology | Myocardial Reperfusion | Coronary Stenosis - physiopathology | Aged | Ontario | Blood Vessel Prosthesis Implantation | Patient Transfer | Myocardial infarction | Clinical Studies | Thrombolysis
Myocardial infarction, Thrombolysis | Clinical trials | Angioplasty | CARDIAC & CARDIOVASCULAR SYSTEMS | THERAPY | myocardial infarction | GUIDELINES | thrombolysis | clinical trials | PRIMARY ANGIOPLASTY | SOCIETY | angioplasty | Postoperative Complications - etiology | Follow-Up Studies | Humans | Middle Aged | Heparin - therapeutic use | Male | Myocardial Infarction - diagnostic imaging | Tissue Plasminogen Activator - therapeutic use | Enoxaparin - therapeutic use | Hospitals, Community | Angioplasty, Balloon, Coronary | Feasibility Studies | Myocardial Infarction - therapy | Time Factors | Fibrinolytic Agents - therapeutic use | Thrombolytic Therapy - methods | Adult | Female | Myocardial Infarction - physiopathology | Tenecteplase | Myocardial Infarction - etiology | Stents | Coronary Stenosis - diagnostic imaging | Length of Stay | Coronary Stenosis - complications | Coronary Stenosis - therapy | Treatment Outcome | Coronary Angiography | Pilot Projects | Heart Conduction System - physiopathology | Myocardial Reperfusion | Coronary Stenosis - physiopathology | Aged | Ontario | Blood Vessel Prosthesis Implantation | Patient Transfer | Myocardial infarction | Clinical Studies | Thrombolysis
Journal Article
01/2012, Third Edition, ISBN 9781437707014
Book Chapter
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.